Blair William & Co. IL Buys 3,733 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Blair William & Co. IL boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 10.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 39,695 shares of the medical device company’s stock after acquiring an additional 3,733 shares during the period. Blair William & Co. IL’s holdings in Cooper Companies were worth $3,465,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of COO. Vanguard Group Inc. boosted its position in shares of Cooper Companies by 303.0% during the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after acquiring an additional 17,367,502 shares during the last quarter. Capital World Investors grew its stake in shares of Cooper Companies by 301.7% in the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after buying an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Cooper Companies by 279.8% in the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after buying an additional 2,532,186 shares during the last quarter. Bessemer Group Inc. raised its position in shares of Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after buying an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB bought a new position in shares of Cooper Companies in the 1st quarter valued at about $139,246,000. 24.39% of the stock is currently owned by institutional investors.

Insider Transactions at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at $520,488.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The disclosure for this sale can be found here. In the last quarter, insiders sold 256,373 shares of company stock valued at $27,637,427. Company insiders own 2.00% of the company’s stock.

Cooper Companies Trading Down 0.5 %

Shares of NASDAQ COO opened at $110.49 on Monday. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The business has a fifty day simple moving average of $97.93 and a two-hundred day simple moving average of $95.45. The firm has a market cap of $22.00 billion, a PE ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period in the previous year, the company posted $0.84 earnings per share. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. Analysts expect that The Cooper Companies, Inc. will post 3.66 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Stifel Nicolaus restated a “buy” rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Piper Sandler increased their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Finally, Morgan Stanley lifted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.